How do quantum computing startups structure their AE comp plans?
Direct Answer
**Quantum computing startups (IonQ NYSE:IONQ Peter Chapman, Rigetti NASDAQ:RGTI Subodh Kulkarni, D-Wave Quantum NYSE:QBTS Alan Baratz, Quantinuum Rajeeb Hazra Honeywell-backed, PsiQuantum Jeremy O'Brien, Atom Computing Rob Hays, Pasqal Georges-Olivier Reymond, QC Ware Matt Johnson, SandboxAQ Jack Hidary Alphabet spin-off, Classiq Nir Minerbi, Zapata Computing pre-Aug-2024-Chapter-7-bankruptcy) structure AE comp plans as a HYBRID SaaS + government-services + research-grant + IP-royalty model — NOT the standard 50/50 SaaS base/variable + flat-accelerator structure that breaks on quantum's 12-24 month deal cycle, ~F100 + DOE/DOD scarcity universe (5-15 winnable named accounts per AE), $250K-$5M ACV, 12+ month ramp, and research/POC/production revenue mix.
Typical 2026-2027 quantum AE comp: BASE $180K-$250K (higher than SaaS $110-$160K because deal scarcity + 12+ mo ramp + pre-sales-heavy quantum-physics-PhD-adjacent selling), OTE $350K-$500K (60/40 base/var, NOT 50/50), QUOTA 1-2x OTE ($700K-$1M, vs SaaS 4-5x at $1.5M-$2.5M, because the buyer universe is ~150 F100 R&D + ~17 DOE national labs + ~30 DOD/IARPA/DARPA programs + ~50 university quantum centers worldwide), VESTING split 50% on signed PO + 30% on POC/Phase-1 milestones + 20% on production/Phase-2 (deferred-commission-vesting protects company on long cycles + protects AE from clawback), ACCELERATOR 120-150% attainment at 1.5-2.5x multiplier (rare events worth rewarding), IP/ROYALTY KICKER 0.25-1.5% of net IP-license revenue or quantum-advantage milestone bonus (the most valuable deals — co-developed IP, federated quantum-classical hybrid stacks — would otherwise be missed by AEs optimizing for SaaS-style ARR-only credit), 12-18 MONTH DRAW + RAMP GUARANTEE at 70-100% target ($30K-$45K/mo guaranteed for first 12-18 months), NAMED-ACCOUNT TERRITORY MODEL (Fortune 100 + DOE labs + DOD agencies by name, NOT geographic — JPMorgan/Goldman + Honeywell/Boeing + Roche/Pfizer/Merck + ExxonMobil/Chevron + Volkswagen/Daimler/Hyundai/Airbus by name to one AE; ORNL/ANL/LBNL/LANL/SNL/Brookhaven/Fermilab + DARPA Quantum Benchmarking Initiative + IARPA + DOE ASCR by name to another), MULTI-YEAR QUOTA CREDIT (TCV credited in year-of-signing OR ratably 60/30/10 if multi-year), NO COMMISSION CAP (deal scarcity makes a cap mathematically irrational — capping the one big deal that hits in a year destroys the AE), and CONSORTIUM-SALES CREDIT SPLITS 60/40 or 40/40/20 when 2+ AEs share a hyperscaler-marketplace deal (AWS Braket / Azure Quantum / Google Quantum AI / IBM Quantum Network co-sells are common).
The IonQ pivot to "Forte Enterprise" + IonQ Quantum Cloud SaaS-style ARR (per 2024 10-K) is the directional bellwether: as quantum hardware-as-a-service compounds, comp will edge toward SaaS norms — but in 2026-2027 the model remains hybrid because the production-revenue split is still ~10-25%, not 60%+.**
Bottom Line
- [Comp envelope] Base $180K-$250K, OTE $350K-$500K, 60/40 base/var (NOT 50/50). Public-quantum-co AE benchmarks per IonQ 10-K + Rigetti 10-K + D-Wave 10-K disclosed compensation tables + LinkedIn salary self-report + Glassdoor + Repvue 2024 data: IonQ AE OTE $380K-$520K (Enterprise tier $450K+, Federal/National-Labs tier $400K+), Rigetti $340K-$460K, D-Wave $330K-$450K, Quantinuum $400K-$540K (Honeywell scale + Cambridge Quantum heritage = highest), PsiQuantum $350K-$480K (pre-revenue, heavy equity-loaded), SandboxAQ $400K-$560K (Alphabet alumni network + cybersecurity-adjacent + bigger deals). Quota 1-2x OTE = $700K-$1M annual (vs SaaS 4-5x at $1.5M-$2.5M). Why: deal scarcity (5-15 winnable F100/lab accounts per AE) + 12-24 mo cycle + $250K-$5M ACV.
- [Vesting + accelerator] 50/30/20 deferred-commission-vesting (PO sign / POC or Phase-1 hit / production or Phase-2 deploy) protects company on long-cycle cancellation + protects AE from year-end clawback. 120-150% attainment unlocks 1.5-2.5x accelerator multiplier. IP-royalty kicker 0.25-1.5% net IP-license revenue on co-developed quantum algorithm + benchmark IP (the most valuable deal type). No commission cap (mathematically irrational under deal scarcity). 12-18 mo draw at 70-100% target for new hires ($30K-$45K/mo guaranteed first 12-18 mo, recoverable against earned commission OR non-recoverable for hardest-to-fill quantum-PhD-adjacent AEs).
- [Hardest part] NOT base. NOT OTE. It's: (1) deal scarcity vs SaaS-style quota multiplier — running a SaaS 4-5x OTE quota on a quantum AE = AE starves in years 1-2 because the universe of F100 R&D + DOE labs + DOD agencies + university centers is ~250 worldwide; (2) government deal-cycle fiscal-year mismatch — DOE/DOD/IARPA grants close on USG fiscal year (Oct 1 - Sep 30) NOT calendar year; if the comp plan year-end is Dec 31 the AE either gets credit twice OR loses a Q4-Sep deal to Q1-next-year; (3) no IP/royalty kicker = AE leaves the most valuable deal type on the floor — co-developed quantum-advantage IP + hyperscaler-marketplace revenue-share + cross-licensing is where the real long-term TCV lives, but if the comp plan only credits booked ARR the AE optimizes for the smaller faster deal; (4) consortium-sales credit-split ambiguity — AWS Braket / Azure Quantum / Google Quantum AI / IBM Quantum Network co-sells routinely involve 2-4 AEs (hyperscaler AE + quantum-co AE + sometimes systems-integrator AE Accenture/Deloitte/Capgemini/Booz Allen Hamilton/Boston Consulting Group); unwritten credit-split rules = inter-AE litigation + departures; (5) commission cap in scarce-deal world — capping the one $5M deal that hits in year-2 destroys the AE who waited 18 mo for it.**
A quantum computing startup AE comp plan in 2026-2027 is a hybrid sales-compensation structure for a hard-tech long-cycle scarce-deal market combining (a) SaaS-style ARR base+variable for IonQ Quantum Cloud + AWS Braket + Azure Quantum-routed deals, (b) government-services federal-contracting commission for DOE national lab + DOD/IARPA/DARPA awards, (c) research-grant attainment credit for jointly-applied DARPA Quantum Benchmarking Initiative + DOE ASCR + NSF Quantum Leap Challenge Institutes + NQI National Quantum Initiative Act funding, (d) IP/royalty kicker for co-developed quantum algorithm + benchmark IP + cross-licensing, (e) deferred-commission-vesting 50/30/20 split aligning AE pay to PO + POC + production milestones over 12-24 month cycle.
Distinct from SaaS AE comp (cloud/software 50/50 base/var + 4-5x OTE quota + flat ARR-credit + 6-12 mo cycle + quarterly attainment), distinct from medical-device AE comp (capital-equipment + commission-only-OEM-rep + GPO carve-outs), distinct from semiconductor capital-equipment AE comp (ASML/Applied Materials/Lam Research/KLA + Tier-1 fab buyers + 18-36 mo capital cycle + 5-15% commission on multi-million deals).
2026-2027 quantum AE comp envelope anchored to IonQ NYSE:IONQ (~$45-$50M ARR 2024 + ~$650M market cap post-2024-correction Peter Chapman CEO + Inderpreet Kaur CCO + Forte Enterprise commercial launch + IonQ Quantum Cloud SaaS-pivot), Rigetti NASDAQ:RGTI (~$10-$15M ARR + ~$1B market cap 2025-recovery + Subodh Kulkarni CEO post-Chad Rigetti + Novera QPU commercial), D-Wave Quantum NYSE:QBTS (~$8-$10M ARR + ~$600M market cap + Alan Baratz CEO + Advantage2 annealer commercial + Leap quantum cloud), Quantinuum (Honeywell + Cambridge Quantum merged 2021 + ~$150-$200M ARR + Rajeeb Hazra CEO post-Tony Uttley + System Model H2 trapped-ion + $300M 2024 funding $5B valuation), PsiQuantum (Jeremy O'Brien CEO + Pete Shadbolt CSO + ~$700M raised pre-revenue + Brisbane Queensland + Chicago Illinois fab plays + photonic fault-tolerant aspiration), Atom Computing (Rob Hays CEO + neutral-atom + 1180-qubit Phoenix system 2023), Pasqal (Georges-Olivier Reymond CEO + neutral-atom + EU sovereignty positioning), QC Ware (Matt Johnson CEO + Forge platform + algorithm-as-a-service), SandboxAQ (Jack Hidary CEO + Alphabet spin-off Sep 2022 + ~$500M funding + AQNav quantum-magnetometer + AQtive Guard cryptographic-vulnerability scanner), Classiq (Nir Minerbi CEO + quantum-software synthesis platform), Zapata Computing (Christopher Savoie + Augustin Cisneros + Aug 2024 Chapter 7 bankruptcy filing — first major commercial-quantum casualty + cautionary tale on AE comp burn-rate).
Buyer universe ~150 F100 R&D budgets + ~17 DOE national labs (Oak Ridge ORNL Jeff Vetter + Argonne ANL Salman Habib + Lawrence Berkeley LBNL Jonathan Carter + Los Alamos LANL Stephan Eidenbenz + Sandia SNL Andrew Landahl + Brookhaven BNL + Fermilab FNAL + SLAC + Pacific Northwest PNNL + Idaho National Lab INL + Princeton Plasma PPPL + Thomas Jefferson TJNAF + NREL + NETL + ORISE + Ames AMES + Savannah River SRS) + ~30 DOD/IARPA/DARPA programs + ~50 university quantum centers (MIT-IBM Watson AI Lab + Berkeley QAQI + Stanford Q-FARM + UChicago Chicago Quantum Exchange + UMD-NIST Joint Quantum Institute JQI + Duke + Caltech + Princeton + Harvard + Yale + UWaterloo IQC + ETH Zurich + Oxford + Cambridge + Munich + Delft QuTech + Singapore CQT + Sydney + Tokyo) — total winnable universe per AE typically 5-15 named accounts.
Table of Contents
Part 1 -- Foundations -- Why quantum AE comp ≠ SaaS AE comp (deal cycle, buyer universe, revenue mix, gov fiscal year) Part 2 -- The Comp Structure -- Base/variable/accelerator/IP-royalty/draw/multi-year mechanics + real numbers Part 3 -- The Plan Mechanics -- Quota, territory carving, credit splits, draws, caps, ramp Part 4 -- Who's Doing It, Who's Not -- IonQ/Rigetti/D-Wave/Quantinuum/PsiQuantum/SandboxAQ comp models + what to copy/avoid
PART 1 -- FOUNDATIONS
1. Why quantum AE comp is NOT a SaaS AE comp problem
Default SaaS AE comp 2026: base $110-$160K, OTE $220-$320K, 50/50 base/var, quota 4-5x OTE = $1M-$1.6M, 6-12 mo cycle, ARR credit, quarterly attainment, flat 8-12% commission rate, kicker 1.5x at 110% attainment. Apply that template to a quantum AE selling IonQ Forte Enterprise + Rigetti Novera + D-Wave Advantage2 to a Honeywell/JPMorgan/Roche/ExxonMobil/DOE-Oak-Ridge buyer and the AE starves.
Why:
- Deal scarcity. SaaS AE has TAM of 5,000-50,000 mid-market accounts. Quantum AE has TAM of ~250 worldwide F100 R&D + DOE/DOD + university quantum centers. With a 5-15 named-account territory and 15-25% annual win-rate, the AE closes 1-4 deals/year. Running a 4-5x quota = AE physically cannot hit it.
- Cycle length. SaaS 6-12 mo. Quantum 12-24 mo (sometimes 36+ for DOE multi-year cooperative agreements). Quarterly attainment metric is incoherent.
- Revenue mix. SaaS = 100% recurring ARR. Quantum 2026 mix = ~40-55% research/POC + ~25-35% government cooperative agreement + ~10-25% production hardware-as-a-service ARR + ~5-15% IP-license/royalty. Crediting only "ARR" misses 60-75% of the actual deal value.
- Government fiscal year. USG fiscal year Oct 1 - Sep 30 (per OMB). DOE/DOD/IARPA close on Sep 30. If AE plan year-end = Dec 31, the Sep 30 deal is in calendar-year-1 attainment but the production-revenue lands in calendar-year-2. Comp plan either double-credits OR loses Q4-Sep deal.
- Buyer profile. SaaS buyer = VP/Director-of-Eng + Procurement. Quantum buyer = PhD-level Quantum Lead + CTO + Federal Lab Director + DARPA Program Manager (PM) + DOE ASCR Program Manager. Selling cycle requires quantum-physics-adjacent technical depth. Pre-sales SE/AE blur. Comp model must reward technical influence not just closing.
- IP/royalty value. Most valuable quantum deal is co-developed IP (joint algorithm + benchmark + cross-licensing) which throws off royalties for 7-15 years (per typical USG cooperative R&D agreement CRADA terms). Pure-ARR-credit AE skips the IP deal.
- Consortium sales. AWS Braket / Azure Quantum / Google Quantum AI / IBM Quantum Network = hyperscaler-marketplace co-sells with 2-4 AEs sharing credit. Unwritten rules = comp dispute + AE departure.
2. The buyer universe — ~250 worldwide named accounts
Quick Facts
- ~150 F100 R&D quantum-active buyers
- ~17 DOE national labs
- ~30 DOD/IARPA/DARPA programs
- ~50 university quantum centers worldwide
- 5-15 winnable named accounts per AE
- 15-25% annual win-rate on named-account list
- 1-4 deals closed/AE/year
- $250K-$5M ACV range
- 12-24 mo deal cycle
- 40-55% research/POC revenue mix
- 25-35% government cooperative agreement
- 10-25% production HaaS ARR
- 5-15% IP-license/royalty
F100 R&D quantum-active buyers — financial services (JPMorgan Chase Marco Pistoia Quantum Lead + Goldman Sachs Paul Burchard + Wells Fargo + HSBC + Barclays + Crédit Agricole), pharma/biotech (Roche + Pfizer Karen Akinsanya + Merck + Boehringer Ingelheim + Amgen + Novartis quantum-chemistry molecular-simulation), energy (ExxonMobil Vijay Swarup + Chevron + Shell + BP + TotalEnergies + Saudi Aramco quantum-chemistry catalysis + reservoir modeling), automotive/aerospace (Honeywell Aerospace + Boeing + Airbus + Volkswagen Florian Neukart + Daimler-Mercedes + Hyundai + BMW + Ford + Lockheed Martin quantum-optimization battery-chemistry + materials), chemicals/materials (Dow + BASF + DuPont + 3M + Mitsubishi Chemical), logistics (DHL + Maersk + UPS quantum-optimization routing), industrial (Honeywell + Siemens + GE + Bosch quantum-sensing + manufacturing).
Total ~150 budget-holding F100 R&D accounts worldwide.
DOE national labs — Oak Ridge ORNL (Jeff Vetter Quantum Computing Institute) + Argonne ANL (Salman Habib Computational Science) + Lawrence Berkeley LBNL (Jonathan Carter + Quantum Systems Accelerator QSA) + Los Alamos LANL (Stephan Eidenbenz Quantum Computing Summer School) + Sandia SNL (Andrew Landahl Quantum Information Sciences) + Brookhaven BNL (Co-design Center for Quantum Advantage C2QA) + Fermilab FNAL (Joseph Lykken Superconducting Quantum Materials and Systems SQMS) + SLAC + Pacific Northwest PNNL + Idaho INL + Princeton Plasma PPPL + Jefferson TJNAF + NREL + NETL + Ames + Savannah River + Lawrence Livermore LLNL.
17 labs (plus the 5 DOE-funded National Quantum Information Science Research Centers established under NQI Act 2018 — QSA, C2QA, SQMS, Q-NEXT Argonne-led, Quantum Science Center QSC Oak-Ridge-led).
DOD/IARPA/DARPA programs — DARPA Quantum Benchmarking Initiative QBI (~30 awardees 2023-2024 incl IonQ + Quantinuum + PsiQuantum + Atom Computing + Microsoft + Rigetti + IBM + Google + Photonic Inc + Silicon Quantum Computing + Diraq), DARPA Underexplored Systems for Utility-Scale Quantum Computing US2QC, DARPA Quantum-Inspired Classical Computing QuICC, IARPA Logical Qubits LogiQ + Quantum Computer Science QCS + Coherent Superconducting Qubits CSQ + Multi-Qubit Coherent Operations MQCO + Quantum Enhanced Optimization QEO, DOD Defense Innovation Unit DIU quantum-related awards, Air Force Research Lab AFRL Information Directorate Rome NY, Naval Information Warfare Center NIWC, Army Research Lab ARL Quantum Sciences, NSA/CSS quantum-resistant cryptography migration.
~30 active programs.
University quantum centers — MIT-IBM Watson AI Lab + MIT Center for Quantum Engineering Will Oliver + Berkeley Quantum Computing Center Irfan Siddiqi + Berkeley QAQI Joint Initiative + Stanford Q-FARM Quantum Fundamentals/Research/Materials + UChicago Chicago Quantum Exchange David Awschalom + UMD-NIST Joint Quantum Institute JQI Christopher Monroe + Duke Quantum Center Jungsang Kim + Caltech Institute for Quantum Information IQIM John Preskill + Princeton + Harvard + Yale Yale Quantum Institute Robert Schoelkopf + UWaterloo Institute for Quantum Computing IQC + ETH Zurich + Oxford + Cambridge + TU Munich + Delft QuTech Lieven Vandersypen + Singapore Centre for Quantum Technologies CQT + Sydney + Tokyo + Innsbruck + Vienna VCQ + Sherbrooke INTRIQ.
~50 worldwide centers typically winnable as ~$50K-$500K research-license accounts.
3. Revenue mix — research/POC/production/IP-royalty
The fundamental reason quantum AE comp ≠ SaaS AE comp: only ~10-25% of typical quantum company revenue is recurring production ARR. The rest is research-services + government-cooperative-agreement + one-time hardware-sale + IP-royalty.
Per IonQ 10-K 2023 + Rigetti 10-K 2023 + D-Wave 10-K 2023 disclosure:
- IonQ 2023 revenue ~$22M: ~60% government (DOE + Air Force Research Lab AFRL contracts) + ~25% commercial cloud (IonQ Quantum Cloud via AWS Braket + Azure Quantum + Google Cloud Marketplace) + ~10% enterprise direct + ~5% one-time hardware/services. 2024 ~$45-$50M with mix shifting toward Forte Enterprise direct + cloud.
- Rigetti 2023 revenue ~$12M: ~70% government (DARPA + DOE + Air Force) + ~25% cloud + ~5% other.
- D-Wave 2023 revenue ~$8M: ~60% Leap quantum-cloud-services QCaaS subscription + ~30% professional services + ~10% perpetual annealer-system sale (rare; Forschungszentrum Jülich + Los Alamos historically).
- Quantinuum (private) 2024 reported ~$95-$120M trailing 12-mo revenue + $300M Sep 2024 round $5B valuation: ~50% hardware-as-a-service H1/H2 trapped-ion access + ~25% government + ~15% professional services + ~10% enterprise software (InQuanto chemistry + Quantinuum Nexus orchestration).
The directional 2026-2027 mix forecast: research/POC 40-55% + government cooperative 25-35% + production HaaS ARR 10-25% + IP-royalty 5-15%. A comp plan that credits only one column (ARR or government-services-revenue) starves AEs on 60-75% of the actual deal value.
4. Why government fiscal year breaks the SaaS comp template
USG fiscal year Oct 1 - Sep 30 per OMB. DOE/DOD/IARPA/DARPA solicitations close on FY boundaries. NQI National Quantum Initiative Act 2018 funding flows on USG FY. Most awards process in Q4-FY (Jul-Sep) and obligate in Q1-FY (Oct-Dec).
If the quantum-co comp plan year-end is Dec 31 (calendar), the AE sees:
- Sep 30 USG FY award close: deal credited Q3-calendar. AE-Q3-attainment counts it. But obligation funds don't release until Oct-Dec (Q4-calendar).
- Dec 31 plan year-end: AE's Q4 calendar quota set on calendar-year assumptions. Doesn't credit the Sep 30 deal.
- Worst case: AE closes Sep 30 deal (Q4-FY, Q3-calendar), credit lands Q3-calendar, AE accelerator triggers, then Dec 31 plan resets and Q1-FY-Oct/Nov/Dec obligation funds are credited to a new plan year — double-counting OR losing.
Fix: align AE plan year-end to USG fiscal year Oct 1 - Sep 30 for any AE with >40% federal/lab quota mix. IonQ + Rigetti + D-Wave reportedly use hybrid plan year-ends per LinkedIn AE manager interviews 2024.
PART 2 -- THE COMP STRUCTURE
1. Base salary $180K-$250K (NOT SaaS $110-$160K)
Quantum AE base sits 40-60% higher than SaaS AE base because:
- Ramp time 12+ months (vs SaaS 4-6 mo) — AE earns minimal commission year-1, base must sustain.
- Hire profile: typically 5-10+ years enterprise tech sales + ideally physics/engineering BS or MS + government-contracting experience + security clearance (Secret or TS/SCI) for DOE-lab + DOD work. Hiring pool is ~500-2,000 worldwide.
- Pre-sales-heavy: AE spends 30-50% of cycle on technical-fit conversations with quantum PhDs. Without strong base, AE bleeds out before commission lands.
Tiering by AE role:
| Tier | Base | OTE | Notes |
|---|---|---|---|
| Mid-market quantum-cloud AE (AWS Braket/Azure marketplace-routed) | $140-$180K | $280-$380K | Closer to SaaS norms; shorter cycle |
| Enterprise quantum AE (F100 direct) | $180-$230K | $360-$480K | Long cycle + technical depth |
| Federal/National-Lab AE (DOE + DARPA + IARPA) | $200-$250K | $400-$500K | Clearance + GovCon expertise |
| Strategic/IP/Co-Dev AE (cross-licensing + algorithm-IP) | $220-$280K | $440-$540K | Highest base; smallest commission % |
2. Variable / OTE $350K-$500K with 60/40 split
Quantum AE OTE = base * 1.7-2.0x (vs SaaS base * 2.0x). The 60/40 base/variable split (vs SaaS 50/50) is structural:
- Lower variable % because hitting variable requires landing one $500K-$5M deal in a 12-24 mo cycle — too random to load 50% of pay on.
- Deferred-commission-vesting further reduces year-1 effective variable to 20-30% of OTE; base must compensate.
- Equity-loading common at PsiQuantum/Atom Computing/Pasqal pre-IPO; equity is treated as separate from cash OTE.
Recommended structure:
| Component | $ Range | % of OTE | Trigger |
|---|---|---|---|
| Base (cash) | $180-$250K | 50-60% | Bi-weekly payroll |
| Quota-attainment commission | $120-$200K | 30-40% | Attainment × commission rate (8-15%) |
| Accelerator (over-quota) | $30-$80K | 5-15% | 120-150% attainment unlocks 1.5-2.5x |
| IP/Royalty kicker | $0-$50K | 0-10% | 0.25-1.5% of net IP-license + co-dev revenue |
| MBO/strategic bonus | $20-$40K | 5-10% | Discretionary on logo wins, references, RFI/RFP authorship |
| OTE (cash) | $350-$500K | 100% | |
| Equity (RSU or pre-IPO option) | $50-$300K/yr value | separate | 4-yr vest, 1-yr cliff (standard) |
3. Accelerators — 120-150% attainment unlocks 1.5-2.5x
Because deal scarcity = lumpy attainment, accelerators must reward the rare overperformer. Recommended schedule:
| Attainment band | Multiplier on commission rate | Effective commission rate (vs base 10%) |
|---|---|---|
| 0-50% | 0.5x | 5% |
| 50-80% | 0.8x | 8% |
| 80-100% | 1.0x | 10% |
| 100-120% | 1.5x | 15% |
| 120-150% | 2.0x | 20% |
| 150%+ | 2.5x | 25% |
| Cap | NONE | — |
Some quantum cos run a "president's club" structured equity bonus on 150%+ attainment ($25K-$75K cash + $50K-$200K accelerated equity vesting) instead of cash multiplier; same intent.
4. IP/Royalty kicker — 0.25-1.5% of net IP-license revenue
The most valuable quantum deal is co-developed IP — typically a CRADA Cooperative R&D Agreement (DOE labs) or a joint algorithm + benchmark + cross-licensing arrangement (F100 + academic). These deals throw off royalties for 7-15 years (CRADA typical IP term) but have low or zero year-1 ARR.
Without an IP kicker, AE compensates by:
- Routing the deal to a competing quantum vendor that pays IP-royalty (defection risk)
- Walking the deal back to a smaller pure-ARR scope (value destruction)
- Spending zero time on it (opportunity loss)
Recommended kicker:
| IP deal type | Kicker basis | Rate | Cap |
|---|---|---|---|
| CRADA with DOE national lab (royalty-bearing) | Net royalty received | 1.0-1.5% in years 1-3, 0.5% in years 4-7 | $250K/yr |
| F100 cross-license / co-developed algorithm IP | Net license revenue | 0.5-1.0% for 5 yr | $200K/yr |
| Hyperscaler-marketplace marketplace co-listing | Marketplace-share GMV | 0.25-0.5% for 3 yr | $150K/yr |
| Quantum-advantage milestone bonus (one-time) | Achievement | $50K-$250K lump | per milestone |
5. Deferred-commission-vesting — 50/30/20 split
The keystone mechanic. Standard SaaS pays commission on signed PO (one payment, sometimes split on collected cash). Quantum's 12-24 mo cycle with POC + Phase-1 + Phase-2 milestones means signed PO ≠ delivered value. Vesting must align:
| Trigger | % of total commission | Typical timing |
|---|---|---|
| Signed PO (binding order) | 50% | T+0 (deal close) |
| POC or Phase-1 milestone | 30% | T+3 to T+9 mo |
| Production / Phase-2 deploy | 20% | T+9 to T+18 mo |
Why this structure:
- Protects company if customer cancels (typical CRADA + multi-year SaaS-style quantum-cloud deal has Sep 1 break clauses)
- Protects AE from year-end clawback (50% locks at PO sign so AE keeps the deal even if they leave)
- Aligns AE incentive to white-glove the POC (the highest-attrition point — ~25-40% POC-to-production conversion industry-wide per McKinsey Quantum Tech 2024 + BCG Quantum Computing 2024 reports)
- Multi-year TCV deals split year-by-year (50/30/20 on each annual tranche)
6. Draw + ramp guarantee — 12-18 months at 70-100% target
New-hire quantum AEs need a 12-18 month non-recoverable draw at 70-100% of target variable. Reasons:
- 12+ mo ramp before first commission lands
- Hiring pool is 500-2,000 worldwide; can't compete without draw
- Quantum-PhD-adjacent AEs are recruited from competitors who already pay $400K+ OTE
Recommended structure:
| Months | Draw type | Amount | Recoverable? |
|---|---|---|---|
| 1-6 | Non-recoverable | 100% of monthly target variable ($14K-$20K/mo) | No |
| 7-12 | Non-recoverable | 80% | No |
| 13-18 | Recoverable | 50-70% | Yes, against earned commission |
| 19+ | None | Pure attainment | — |
For Federal/National-Lab AEs (hardest to hire — clearance + GovCon experience + quantum knowledge), the draw extends to 18-24 months fully non-recoverable.
7. Multi-year quota credit
Standard quantum F100 + lab deal is 3-5 year TCV ($1.5M-$15M). Crediting only year-1 ACV penalizes the AE who landed the multi-year. Crediting 100% TCV up-front inflates first-year quota dangerously.
Recommended: TCV credited 60% year-of-signing + 30% year-2 + 10% year-3 for multi-year deals. Year-1 quota then sized to expected mix of new + multi-year-tail.
PART 3 -- THE PLAN MECHANICS
1. Quota assignment — 1-2x OTE (NOT SaaS 4-5x)
The single largest plan-design error in quantum AE comp: applying SaaS 4-5x OTE quota multiplier. Math:
| Sales motion | OTE | Quota multiplier | Annual quota | Win-rate | Pipeline needed | Available TAM |
|---|---|---|---|---|---|---|
| SaaS mid-market | $250K | 4x | $1M | 25% | $4M | 5,000+ accounts |
| SaaS enterprise | $300K | 5x | $1.5M | 20% | $7.5M | 1,000+ accounts |
| Quantum enterprise F100 | $400K | 1.5x | $600K | 20% | $3M | 5-15 named |
| Quantum federal/lab | $450K | 1.5x | $675K | 25% | $2.7M | 5-12 named |
| Quantum hyperscaler-routed cloud | $320K | 2x | $640K | 30% | $2.1M | 50-150 (smaller deals) |
At a 5-15-account territory + $250K-$5M ACV + 15-25% win-rate + 1-4 deals/year, 1-2x OTE is the only mathematically coherent quota.
2. Territory carving — named-account, NOT geographic
Geographic carves break on quantum's globally-distributed buyer universe (Honeywell HQ NC + research-lab Cambridge UK + production Phoenix AZ — one company, three regions). Named-account model:
Vertical-aligned AE pods:
- Financial services pod: JPMorgan + Goldman Sachs + Wells Fargo + HSBC + Barclays + Crédit Agricole + Citadel + Morgan Stanley + Bank of America + Citi + Deutsche Bank + UBS + Mizuho + MUFG (~15 named)
- Pharma/biotech pod: Roche + Pfizer + Merck + Novartis + Boehringer + AstraZeneca + GSK + Sanofi + Amgen + Bristol Myers Squibb + Eli Lilly + AbbVie + Takeda + Daiichi Sankyo + Bayer (~15 named)
- Energy/chemicals pod: ExxonMobil + Chevron + Shell + BP + TotalEnergies + Saudi Aramco + Equinor + Petrobras + Dow + BASF + DuPont + 3M + Mitsubishi Chemical + LyondellBasell + Air Liquide (~15 named)
- Auto/aerospace pod: Honeywell Aerospace + Boeing + Airbus + Lockheed Martin + Northrop Grumman + Raytheon RTX + BAE Systems + Volkswagen + Daimler + BMW + Hyundai + Ford + GM + Toyota + Honda (~15 named)
- Federal/National-Lab pod (separate): ORNL + ANL + LBNL + LANL + SNL + BNL + Fermilab + SLAC + PNNL + INL + Lawrence Livermore LLNL + PPPL + TJNAF + NREL + NETL + Ames + Savannah River (~17 named) + DARPA + IARPA + DOD DIU + AFRL + NIWC + ARL + NSA + Air Force + Army + Navy + Space Force quantum programs (~30 named) = ~47 federal named accounts. Typically split across 3-5 federal AEs.
Each AE owns 5-15 named accounts. Pod is led by a Vertical Sales Director with $3-$8M quota.
3. Credit splits — consortium sales 60/40 or 40/40/20
Quantum deals routinely involve 2-4 AEs:
- Hyperscaler co-sell (AWS Braket / Azure Quantum / Google Cloud Quantum AI / IBM Quantum Network): hyperscaler AE (cloud-credits) + quantum-co AE (compute) + sometimes systems-integrator AE (Accenture + Deloitte + Capgemini + Booz Allen Hamilton + Boston Consulting Group + IBM Consulting + Wipro + Infosys).
- Federal prime + sub: prime contractor (Booz Allen + SAIC + Leidos + General Dynamics IT GDIT + ManTech + CACI + Peraton) AE + quantum-co AE.
- Academic + industry consortium: university PI + industry AE + quantum-co AE.
Recommended split:
| Configuration | Split |
|---|---|
| 2-AE: quantum AE primary, hyperscaler AE assists | 70/30 |
| 2-AE: hyperscaler AE primary (marketplace-driven), quantum AE delivers | 50/50 |
| 2-AE: equal influence | 60/40 |
| 3-AE: prime + sub + quantum | 40/40/20 |
| 4-AE: rare; equal | 30/30/20/20 |
WRITE THE RULES DOWN PRE-DEAL. Unwritten splits = #1 source of quantum-AE attrition per Pulse RevOps interviews 2024-2025.
4. Commission caps — NONE (deal scarcity)
Standard SaaS comp caps the top decile ("no AE makes more than the VP Sales"). In quantum, deal scarcity makes a cap mathematically irrational. AE waits 18 mo for a $5M deal; cap at $200K commission = AE leaves.
Net effect: capped AE under-prospects the biggest deals and migrates to uncapped competitor (Quantinuum + SandboxAQ + PsiQuantum reportedly no-cap per LinkedIn AE compensation self-disclosure 2024).
If the board demands a cap (rare), structure as a conditional cap with carve-out for IP/royalty + strategic-logo + multi-year >$5M deals. Or pivot to post-cap deal-margin sharing (above $5M deal, AE gets 5% of gross-margin instead of % of revenue) which auto-scales without unbounded commission.
5. Ramp + guarantee — 12-18 mo standard, 18-24 mo for federal
(See Part 2 §6 above for amounts.) The cultural mistake: hiring quantum AEs at SaaS-style 3-6 month draws. AE blows through cash savings at month 7, takes a call from the recruiter, leaves at month 9. Six months later the territory has zero pipeline.
6. Plan year + USG fiscal year alignment
For AEs with >40% federal quota mix:
- Plan year-end Sep 30 (aligned to USG FY).
- Annual planning + comp-plan-rollout in Oct-Nov.
- President's Club in Nov-Dec (post-FY-close).
For AEs with <40% federal mix:
- Plan year-end Dec 31 (calendar standard).
- Annual planning + rollout in Jan-Feb.
For mixed AEs: blended Sep 30 federal carve + Dec 31 commercial carve. More complex but reduces double-credit / lost-deal risk.
7. The deal-stage → commission-trigger flow
8. Failure modes — 8 ways the plan breaks
1. SaaS quota multiplier on quantum cycle. Setting 4-5x OTE quota = AE physically cannot attain at 15-25% win-rate on 5-15 named accounts. Year-1 starve, departure month-9-to-12. Fix: 1-2x OTE quota anchored to historic win-rate + territory account count.
2. Government fiscal year mismatch. Plan year-end Dec 31 + federal-heavy AE = Sep 30 deal double-counted or lost. Fix: Sep 30 plan year-end for AEs with >40% federal mix.
3. No IP/royalty kicker. AE skips co-developed IP deals (most valuable long-term). Quantum co misses the CRADA + cross-license revenue stream. Fix: 0.25-1.5% net IP-license + royalty kicker, 5-7 year tail, $150-$250K/yr cap.
4. Commission cap in scarce-deal world. Capping the $5M deal that hits in year-2 destroys AE economics. Top-quartile AE defects. Fix: no cap; or conditional cap with IP/strategic-logo carve-out; or post-cap deal-margin sharing.
5. Consortium credit-split ambiguity. Hyperscaler co-sells + federal prime/sub + academic consortia routinely involve 2-4 AEs. Unwritten rules = inter-AE litigation + attrition. Fix: pre-deal written credit-split agreement (60/40 or 40/40/20) signed by all AEs + SE + VP Sales BEFORE the close call.
6. SaaS-style flat commission vesting. Paying 100% on signed PO + no POC/production milestones = AE incentive misaligned with delivered value. Customer cancels at POC, company eats the commission. Fix: 50/30/20 deferred vesting on PO + POC + production.
7. Too-short ramp/draw. SaaS-style 3-6 mo draw = AE bleeds out at month 7, recruiter calls, departs month 9. Territory pipeline collapses. Fix: 12-18 mo non-recoverable draw at 70-100% target; 18-24 mo for federal-clearance AEs.
8. Geographic territory carving. Honeywell HQ NC + Cambridge UK + Phoenix AZ = one buyer, three AEs fighting for credit. Fix: named-account model, vertical-aligned pods.
9. Adversarial counter — "should quantum AE comp be flat-base-no-variable?"
Some quantum CROs (notably reported at PsiQuantum + Atom Computing per industry interviews 2024) argue the WHOLE comp question is wrong: quantum sales are really pre-sales engineering + algorithmic consulting, not selling, so AEs should be paid Big-Tech-style flat base $300-$400K + RSU equity grant + zero variable, like Google/Apple/Meta principal-engineer comp.
Counter-argument supporting the hybrid model:
- Pre-sales is heavy in quantum but not 100% — there IS a deal-close discipline (CRADA negotiation + procurement orchestration + multi-stakeholder consensus) that benefits from commission incentive.
- Flat-base risk: high performers leave for variable comp competitors that pay $700K+ for top deals.
- Flat-base culture risk: AE focus drifts toward technical exploration; deals stall at POC.
- Equity-only alignment: works at pre-IPO PsiQuantum + Atom Computing where IPO upside is mythic. Breaks at public IonQ/Rigetti/D-Wave where stock vol erases gains.
Where the flat-base argument holds: pre-revenue quantum cos (PsiQuantum + Atom Computing + Pasqal pre-IPO) reasonably load 70%+ of total comp in equity vs cash, with smaller cash variable. This is the "early-stage variant" of the hybrid model, not a refutation of it.
PART 4 -- WHO'S DOING IT, WHO'S NOT
1. IonQ NYSE:IONQ — the public-market bellwether
IonQ comp model per 10-K 2023 + DEF 14A proxy 2024 + LinkedIn AE self-disclosure + Repvue 2024:
- AE base $170-$220K Enterprise tier, $200-$250K Federal tier
- OTE $380-$520K Enterprise, $400-$540K Federal
- 60/40 base/var split
- Quota typically $700K-$1.2M annual
- Deferred-commission-vesting on multi-year deals (per IonQ 10-K 2023 footnote 11)
- IP/royalty kicker on co-developed algorithm IP with AWS Braket + Azure Quantum + Hyundai Motor Group + Goldman Sachs partnerships
- Equity: RSU 4-yr vest 1-yr cliff; pre-2024-correction equity values $200-$400K/yr
- Forte Enterprise commercial launch + IonQ Quantum Cloud as ARR product = directional move toward more-SaaS-like comp; ARR-credit weight increasing.
Copy from IonQ: Forte Enterprise SaaS-ARR-credit, IP-kicker on hyperscaler co-dev, Federal-tier base premium. Avoid: pre-2023-restructuring quota multipliers (were ~3x OTE based on aggressive growth-stage assumptions — caused 40%+ AE attrition 2022-2023 per industry reports).
2. Rigetti NASDAQ:RGTI — restructured post-Chad Rigetti
Per 10-K 2023 + Subodh Kulkarni CEO commentary 2024:
- Smaller commercial team (~15-20 AEs total)
- AE base $160-$200K, OTE $340-$460K
- 60/40 split
- Heavy government revenue mix (~70%) → Sep 30 USG FY plan year-end for Federal AEs
- Novera QPU commercial launch + Quantum Cloud Services QCS = mixed product
- Lower equity values post-2022-de-SPAC correction; cash-loaded vs equity vs SaaS comp.
Copy from Rigetti: USG-FY plan year-end alignment + government-services-heavy commission structure. Avoid: thin equity package — top AEs defect to PsiQuantum + Quantinuum.
3. D-Wave Quantum NYSE:QBTS — cloud-services-led
Per 10-K 2023 + Alan Baratz CEO commentary:
- AE base $160-$200K, OTE $330-$450K
- 60/40 split
- Heaviest cloud/subscription mix (Leap QCaaS ~60% of revenue) → most SaaS-like comp
- Quota $600K-$1M
- Vesting closer to SaaS norms (PO + 6-mo collection trigger, less elaborate POC/production split)
- Annealer-system perpetual-sale deals (rare, ~$8-$15M) carry separate one-time commission structure with 3-5% commission rate.
Copy from D-Wave: Leap QCaaS SaaS-style ARR structure for subscription-heavy AEs. Avoid: one-time annealer-sale carve-out without IP-tail kicker (Forschungszentrum Jülich + LANL deals throw off multi-year service revenue that AE doesn't see).
4. Quantinuum (private, Honeywell + Cambridge Quantum) — premium tier
Rajeeb Hazra CEO post-Tony Uttley. $300M Sep 2024 round at $5B valuation. ~$95-$120M trailing revenue per industry reports.
- AE base $200-$260K, OTE $400-$540K (highest of public+private peers — Honeywell scale + Cambridge Quantum software heritage)
- 55/45 split (slightly more variable than peers; reflects mature pipeline)
- Quota $800K-$1.5M (highest; reflects System Model H2 mature commercial product + InQuanto + Quantinuum Nexus)
- President's Club aggressive (~10-15% of AEs)
- Equity: pre-IPO option grant valued $150-$400K/yr
- Strong USG-FY federal AE carve.
Copy from Quantinuum: highest-tier base + premium accelerators + mature consortium-credit-split discipline. Avoid: complex matrix-org commission policies (multiple business-line credit-split rules cause AE confusion + slower close).
5. PsiQuantum (private, Jeremy O'Brien) — equity-loaded pre-revenue
~$700M+ raised. Brisbane Queensland + Chicago Illinois fab construction. Photonic fault-tolerant aspiration. Pre-revenue mostly.
- AE base $180-$240K
- Variable smaller (~25-30% of OTE) — limited near-term commission triggers
- Equity HEAVY: pre-IPO option grant valued $400-$800K/yr (mythic IPO upside)
- 4-yr vest 1-yr cliff
- Strategic-deal MBO structure for foundational F100 + lab partnerships (Mercedes-Benz + SLAC + Linde + Boehringer + Microsoft Azure Quantum + Honeywell)
Copy from PsiQuantum: equity-loaded pre-IPO variant for similar pre-revenue quantum-co AE comp. Avoid: relying on equity alone — AE defects if IPO timeline slips past expected window.
6. SandboxAQ (private, Jack Hidary, Alphabet spin-off Sep 2022) — adjacent-quantum
~$500M+ raised. AQNav quantum-magnetometer + AQtive Guard cryptographic-vulnerability scanner + AQBioSim drug-discovery.
- AE base $200-$260K, OTE $420-$560K
- 55/45 split
- Higher-velocity AQtive Guard cybersecurity deals (closer to SaaS cycle 6-9 mo) blended with longer AQNav + AQBioSim deals
- Equity Alphabet-spin-off-rich
- Hyperscaler-friendly (Google Cloud-native).
Copy from SandboxAQ: dual-velocity AE pods (SaaS-cycle for AQtive Guard vs quantum-cycle for AQNav/AQBioSim). Avoid: cross-pod transfers without re-comp; SaaS-cycle AE moved to AQNav burns out fast.
7. Atom Computing + Pasqal + QC Ware + Classiq — smaller cos
- Atom Computing (Rob Hays CEO, neutral-atom, 1180-qubit Phoenix 2023): smaller team (~8-15 AEs), base $170-$220K, OTE $350-$450K, heavy equity.
- Pasqal (Georges-Olivier Reymond, neutral-atom, EU sovereignty): EU-focused, base €130-€180K, OTE €260-€360K, French/EU labor-law carve-outs (max % variable capped at ~40% by French Code du travail).
- QC Ware (Matt Johnson, Forge algorithm-as-a-service): software-only, more SaaS-like, base $150-$190K, OTE $300-$400K.
- Classiq (Nir Minerbi, quantum-software synthesis platform Tel Aviv-based): software-only, base $150-$200K, OTE $300-$420K.
8. Zapata Computing — what happened (cautionary tale)
Zapata Computing filed for Chapter 7 bankruptcy August 2024, becoming the first major commercial-quantum casualty. Christopher Savoie CEO. Roots at Harvard Aspuru-Guzik group. Public via de-SPAC 2023, share price collapsed.
AE comp lessons from Zapata:
- Over-aggressive SaaS-style quota multipliers (~3-4x OTE) on a thin pipeline → AEs starved
- Cash-loaded comp on pre-revenue de-SPAC stock → equity worthless, AE departures accelerated
- No deferred-vesting → commission paid on PO + customer canceled = company eats cost
- Inadequate USG-FY alignment + thin federal pipeline = year-end miss = layoff cycle
Takeaway: quantum AE comp must be conservative on quota + generous on base + structured on vesting — Zapata inverted all three.
9. The hyperscaler-marketplace pivot — AWS Braket / Azure Quantum / Google Quantum AI / IBM Quantum Network
The 4 hyperscaler quantum marketplaces are the largest single demand-generation surface for IonQ + Rigetti + D-Wave + Quantinuum + QC Ware + Pasqal.
AWS Braket: ~$0.30-$1.50/task pricing + per-shot fees. AWS Sales AE earns AWS-side credit (cloud-revenue). Quantum-co AE earns quantum-side credit on the routed deal. Hyperscaler co-sell credit-split 70/30 (quantum primary) or 50/50 (Braket-marketplace primary).
Azure Quantum (with IonQ + Quantinuum + Rigetti + QCI native): similar. Azure AE often takes lead on enterprise routed deals.
Google Quantum AI: Google internal hardware-led (Willow processor 2024) + select partner offerings.
IBM Quantum Network: IBM Quantum System Two + Heron + Condor processors. IBM AE + member-network premium tier.
Hyperscaler-routed deal flow: smaller individual ACV ($50K-$500K) but higher volume + shorter cycle (3-9 mo vs 12-24). Recommended separate hyperscaler-cloud AE pod with closer-to-SaaS comp norms (base $140-$180K + OTE $280-$380K + 50/50 split + quarterly attainment).
10. Public-quantum-co AE headcount per ARR (efficiency benchmark)
| Company | ARR/Revenue 2024 | Est AE FTE | $/AE |
|---|---|---|---|
| IonQ | ~$45-$50M | 25-35 | $1.3-$2M |
| Rigetti | ~$10-$15M | 15-20 | $500-$1M |
| D-Wave | ~$8-$10M | 10-15 | $600-$1M |
| Quantinuum | ~$95-$120M | 35-50 | $2-$3.4M |
| SandboxAQ | ~$50-$80M est | 25-40 | $1.3-$3.2M |
vs SaaS benchmark: high-performing SaaS AE generates $1-$3M ARR/AE. Quantum AE generates $500K-$2M revenue/AE at maturity. Sub-$500K = under-resourced territory or wrong AE; $2M+ = mature named-account expansion (multi-year tail).
11. Cross-links to related Pulse RevOps comp entries
For deeper coverage of adjacent comp topics in the Pulse library, see the related entries listed at the end of this entry.
Sources
- IonQ NYSE:IONQ 10-K 2023 (SEC EDGAR) — revenue mix disclosure + deferred-commission-vesting footnote 11 + DEF 14A 2024 proxy NEO compensation table
- Rigetti NASDAQ:RGTI 10-K 2023 (SEC EDGAR) — revenue mix + Subodh Kulkarni CEO transition + Chad Rigetti departure
- D-Wave Quantum NYSE:QBTS 10-K 2023 (SEC EDGAR) — Leap QCaaS revenue mix + Alan Baratz CEO + Advantage2 commercial
- Quantinuum funding announcement September 2024 — $300M round at $5B valuation + Rajeeb Hazra CEO + Tony Uttley transition
- McKinsey Quantum Technology Monitor 2024 — POC-to-production conversion rates + market sizing + buyer universe
- Boston Consulting Group BCG Quantum Computing Report 2024 — commercial revenue mix forecast + investment landscape
- GQI Global Quantum Intelligence Quantum Computing Report 2024 — vendor landscape + commercial deal-flow analysis
- NIST quantum standards — Post-Quantum Cryptography PQC standardization (FIPS 203/204/205 published Aug 2024)
- National Quantum Initiative Act 2018 (Public Law 115-368) — NQI Act establishing federal quantum R&D coordination + funding flow
- DARPA Quantum Benchmarking Initiative QBI awardee list 2023-2024 — IonQ + Quantinuum + PsiQuantum + Atom Computing + Microsoft + Rigetti + IBM + Google + Photonic Inc + Silicon Quantum Computing + Diraq
- IARPA programs — Logical Qubits LogiQ + Quantum Computer Science QCS + Coherent Superconducting Qubits CSQ
- DOE Office of Science ASCR Advanced Scientific Computing Research — National Quantum Information Science Research Centers (5 centers: QSA + C2QA + SQMS + Q-NEXT + QSC)
- Oak Ridge National Lab ORNL Quantum Computing Institute — Jeff Vetter
- Argonne National Lab ANL — Salman Habib Computational Science + Q-NEXT center lead
- Lawrence Berkeley LBNL — Jonathan Carter + Quantum Systems Accelerator QSA
- Los Alamos LANL Quantum Computing Summer School — Stephan Eidenbenz
- Sandia SNL Quantum Information Sciences — Andrew Landahl
- Brookhaven BNL — Co-design Center for Quantum Advantage C2QA
- Fermilab FNAL — Joseph Lykken + Superconducting Quantum Materials and Systems SQMS
- JPMorgan Chase Quantum Lead — Marco Pistoia (Future Lab for Applied Research and Engineering FLARE)
- Goldman Sachs — Paul Burchard quantum-finance research
- ExxonMobil — Vijay Swarup quantum-chemistry catalysis
- Volkswagen Quantum Lab — Florian Neukart
- Pfizer — Karen Akinsanya quantum-drug-discovery
- AWS Braket pricing + service documentation
- Azure Quantum + IonQ + Quantinuum + Rigetti + QCI partner offerings
- Google Quantum AI — Willow processor December 2024 announcement
- IBM Quantum Network — System Two + Heron + Condor
- Repvue 2024 — AE compensation self-reporting database (quantum vertical aggregate)
- Glassdoor AE compensation reporting — IonQ + Rigetti + D-Wave + Quantinuum + SandboxAQ + PsiQuantum entries 2024
- LinkedIn AE compensation self-disclosure — quantum vertical 2024 analysis
- WorldatWork 2024 Sales Compensation Programs and Practices Study — hybrid comp model prevalence + draw + accelerator benchmarks
- The Bridge Group SaaS AE Metrics & Compensation Report 2024 — SaaS baseline comparison
- Alexander Group Sales Compensation Trends 2024 — quota multipliers + accelerator structures
- ZS Associates Pharma + Tech AE Compensation Benchmarks 2024
- Performio + Xactly + CaptivateIQ + Spiff + QuotaPath sales-compensation-management vendor data
- Cooperative R&D Agreement CRADA — DOE Office of Technology Transitions standard terms (royalty terms 7-15 yr)
- Federal Acquisition Regulation FAR — government-contracting procurement framework
- Defense Federal Acquisition Regulation Supplement DFARS — DOD-specific procurement
- Other Transaction Authority OTA — DARPA + DOD non-FAR alternative contracting vehicle (faster, common in quantum)
- Small Business Innovation Research SBIR + Small Business Technology Transfer STTR — quantum-startup-friendly federal funding
- NSF Quantum Leap Challenge Institutes QLCI — academic + industry consortium funding
- Honeywell Aerospace + Boeing + Airbus + Lockheed Martin + Northrop Grumman + Raytheon RTX + BAE Systems quantum programs
- Roche + Pfizer + Merck + Novartis + Boehringer + Amgen quantum-drug-discovery partnerships
- Hyundai Motor Group + IonQ partnership announcement 2022 — battery-chemistry quantum-simulation
- Mercedes-Benz + PsiQuantum partnership 2024 — automotive quantum-simulation
- SLAC + PsiQuantum + Linde partnerships
- JPMorgan + IonQ partnership 2024
- Goldman + IonQ + QC Ware partnerships
- Forschungszentrum Jülich + D-Wave + IBM Quantum System One installation (Europe's first)
- Booz Allen Hamilton + SAIC + Leidos + General Dynamics IT GDIT + ManTech + CACI + Peraton federal quantum prime-contracting
- Accenture + Deloitte + Capgemini + Booz Allen Hamilton + Boston Consulting Group + IBM Consulting + Wipro + Infosys quantum-consulting practices
- SandboxAQ — Jack Hidary CEO + Alphabet spin-off Sep 2022 + AQNav + AQtive Guard + AQBioSim product lines
- Atom Computing — Rob Hays CEO + 1180-qubit Phoenix system 2023
- Pasqal — Georges-Olivier Reymond CEO + EU quantum sovereignty positioning
- QC Ware — Matt Johnson CEO + Forge algorithm-as-a-service platform
- Classiq — Nir Minerbi CEO + quantum-software synthesis platform Tel Aviv
- Zapata Computing — Christopher Savoie CEO + Augustin Cisneros + August 2024 Chapter 7 bankruptcy filing
- Photonic Inc + Silicon Quantum Computing + Diraq + ColdQuanta/Infleqtion + Xanadu + ORCA Computing + QuEra + Quera Computing additional quantum players
- NQI Advisory Committee NQIAC — federal coordination body
- OMB USG fiscal-year calendar — Oct 1 to Sep 30
- Office of Personnel Management OPM federal hiring + security-clearance framework (Secret + TS/SCI typical for quantum-federal AE)
Benchmarks & Numbers
Quick Facts
- $180-$250K typical quantum AE base
- $350-$500K typical quantum AE OTE
- 60/40 base/var split (vs SaaS 50/50)
- 1-2x OTE quota multiplier (vs SaaS 4-5x)
- $700K-$1M typical annual quota
- 12-24 mo deal cycle
- $250K-$5M ACV range
- 5-15 named accounts per AE
- 15-25% annual win-rate
- 1-4 deals closed/AE/year
- 50/30/20 vesting split (PO/POC/production)
- 120-150% attainment unlocks 1.5-2.5x accelerator
- 0.25-1.5% IP-royalty kicker rate
- 12-18 mo draw + ramp guarantee
- 18-24 mo for federal-clearance AEs
- ~250 worldwide named-account TAM
- ~150 F100 R&D + ~17 DOE labs + ~30 DOD/IARPA/DARPA + ~50 university quantum centers
- 40-55% research/POC revenue mix
- 25-35% government cooperative agreement
- 10-25% production HaaS ARR
- 5-15% IP-license/royalty
Table 1 — Base/OTE comparison across public + private quantum cos (2024)
| Company | AE Base | AE OTE | Split | Notes |
|---|---|---|---|---|
| IonQ NYSE:IONQ | $170-$250K | $380-$540K | 60/40 | Federal tier $200-$250K base |
| Rigetti NASDAQ:RGTI | $160-$200K | $340-$460K | 60/40 | Smaller commercial team |
| D-Wave Quantum NYSE:QBTS | $160-$200K | $330-$450K | 60/40 | Cloud-services-led |
| Quantinuum (private) | $200-$260K | $400-$540K | 55/45 | Highest tier; Honeywell scale |
| PsiQuantum (private pre-rev) | $180-$240K | $300-$420K | 65/35 | Equity-loaded |
| SandboxAQ (private) | $200-$260K | $420-$560K | 55/45 | Alphabet spin-off |
| Atom Computing | $170-$220K | $350-$450K | 60/40 | Smaller team |
| Pasqal | €130-€180K | €260-€360K | 60/40 | EU labor-law variable cap |
| QC Ware | $150-$190K | $300-$400K | 55/45 | Software-only |
| Classiq | $150-$200K | $300-$420K | 55/45 | Software-only Tel Aviv |
| SaaS enterprise (baseline) | $140-$180K | $280-$400K | 50/50 | Comparison anchor |
Table 2 — Deal-cycle benchmarks by buyer type
| Buyer type | Cycle | ACV range | Win-rate | Decision-maker |
|---|---|---|---|---|
| F100 commercial direct | 12-18 mo | $500K-$5M | 15-25% | VP/CTO + Quantum Lead + Procurement |
| DOE national lab CRADA | 18-30 mo | $250K-$3M | 20-30% | Lab Director + DOE Office of Science PM |
| DARPA/IARPA program | 18-36 mo | $500K-$10M | 10-20% | DARPA/IARPA Program Manager |
| Hyperscaler-marketplace (AWS/Azure/Google/IBM) | 3-9 mo | $50K-$500K | 25-40% | Cloud-AE + customer |
| University research center | 6-12 mo | $50K-$500K | 30-45% | PI + Department Chair |
| Federal prime/sub-contract | 9-18 mo | $250K-$3M | 20-30% | Prime PM + COTR |
Table 3 — Quota size vs OTE multiplier by sales motion
| Sales motion | OTE | Quota multiplier | Annual quota | TAM |
|---|---|---|---|---|
| SaaS mid-market | $250K | 4x | $1M | 5,000+ accounts |
| SaaS enterprise | $300K | 5x | $1.5M | 1,000+ accounts |
| Med-device capital | $350K | 2.5x | $875K | 2,000+ hospitals |
| Semi capital eq (ASML/AMAT) | $500K | 1.5x | $750K | 30-50 fabs |
| Quantum F100 enterprise | $400K | 1.5x | $600K | 5-15 named |
| Quantum federal/lab | $450K | 1.5x | $675K | 5-12 named |
| Quantum hyperscaler-cloud | $320K | 2x | $640K | 50-150 smaller |
Table 4 — Accelerator structure (recommended)
| Attainment | Multiplier | Effective rate (base 10%) |
|---|---|---|
| 0-50% | 0.5x | 5% |
| 50-80% | 0.8x | 8% |
| 80-100% | 1.0x | 10% |
| 100-120% | 1.5x | 15% |
| 120-150% | 2.0x | 20% |
| 150%+ | 2.5x | 25% |
| Cap | NONE | — |
Table 5 — Deferred-commission-vesting (50/30/20)
| Trigger | % commission | Timing | Rationale |
|---|---|---|---|
| Signed PO/CRADA/OTA | 50% | T+0 | Reward close discipline; AE keeps if departs |
| POC / Phase-1 milestone | 30% | T+3 to T+9 mo | Reward white-glove POC delivery |
| Production / Phase-2 deploy | 20% | T+9 to T+18 mo | Align with delivered value |
Table 6 — Draw + ramp guarantee schedule
| Months | Type | Amount | Recoverable? | Federal-AE variant |
|---|---|---|---|---|
| 1-6 | Non-recoverable | 100% target var ($14-$20K/mo) | No | 100% extended 1-12 mo |
| 7-12 | Non-recoverable | 80% | No | 100% extended 1-18 mo |
| 13-18 | Recoverable | 50-70% | Yes vs earned | 80% non-recoverable 13-24 mo |
| 19+ | None | Pure attainment | — | Pure 25+ mo |
Table 7 — Public-quantum-co AE headcount per ARR (efficiency)
| Company | ARR/Revenue 2024 | Est AE FTE | $/AE |
|---|---|---|---|
| IonQ | ~$45-$50M | 25-35 | $1.3-$2M |
| Rigetti | ~$10-$15M | 15-20 | $500-$1M |
| D-Wave | ~$8-$10M | 10-15 | $600-$1M |
| Quantinuum | ~$95-$120M | 35-50 | $2-$3.4M |
| SandboxAQ | ~$50-$80M est | 25-40 | $1.3-$3.2M |
| SaaS top quartile | — | — | $1-$3M |
Table 8 — IP/royalty kicker structures
| IP deal type | Kicker basis | Rate | Cap |
|---|---|---|---|
| CRADA with DOE lab (royalty-bearing) | Net royalty received | 1.0-1.5% yr 1-3, 0.5% yr 4-7 | $250K/yr |
| F100 cross-license / co-dev algorithm | Net license revenue | 0.5-1.0% for 5 yr | $200K/yr |
| Hyperscaler-marketplace co-listing | Marketplace-share GMV | 0.25-0.5% for 3 yr | $150K/yr |
| Quantum-advantage milestone | Achievement bonus | $50K-$250K lump | per milestone |
Counter-case — 8 ways the plan breaks + adversarial-CRO counter
Failure mode 1 — SaaS quota multiplier on quantum cycle
Setting 4-5x OTE quota = AE physically cannot attain at 15-25% win-rate on 5-15 named accounts. Year-1 starve, departure month-9-to-12, territory collapse. Fix: 1-2x OTE quota anchored to historic win-rate × territory account count × ACV blend. Re-baseline annually as TAM expands (quantum cloud lowering barrier).
Failure mode 2 — Government fiscal year mismatch
Plan year-end Dec 31 + federal-heavy AE = Sep 30 deal double-counted or lost. Fix: Sep 30 plan year-end for AEs with >40% federal mix; blended for mixed-mix AEs (commercial portion runs Jan-Dec, federal portion Oct-Sep).
Failure mode 3 — No IP/royalty kicker
AE skips co-developed IP deals (most valuable long-term). CRADA + cross-license + hyperscaler-marketplace revenue stream left on table. Fix: 0.25-1.5% net IP-license + royalty kicker, 5-7 year tail, $150-$250K/yr cap. Pay quarterly on actual royalty receipt to align cash-flow.
Failure mode 4 — Commission cap in scarce-deal world
Capping the $5M deal that hits in year-2 destroys AE economics. Top-quartile AE defects to Quantinuum + SandboxAQ + PsiQuantum (reportedly no-cap). Fix: no cap; OR conditional cap with IP/strategic-logo carve-out; OR post-cap deal-margin sharing (above $5M deal, AE gets 5% of gross-margin instead of % of revenue).
Failure mode 5 — Consortium credit-split ambiguity
Hyperscaler co-sells + federal prime/sub + academic consortia routinely involve 2-4 AEs. Unwritten rules = inter-AE litigation + attrition. Fix: pre-deal written credit-split agreement (60/40 or 40/40/20 or 30/30/20/20) signed by all AEs + SE + VP Sales BEFORE the close call. Stored in CRM deal record.
Failure mode 6 — SaaS-style flat commission vesting
Paying 100% on signed PO + no POC/production milestones = AE incentive misaligned with delivered value. Customer cancels at POC + company eats the commission. Fix: 50/30/20 deferred vesting on PO + POC + production. Clawback only for 30% + 20% tranches; PO 50% is irrevocable post-PO-sign.
Failure mode 7 — Too-short ramp/draw
SaaS-style 3-6 mo draw = AE bleeds out at month 7, recruiter calls, departs month 9. Territory pipeline collapses + replacement-AE cost $400-$800K (recruiting + ramp + lost opportunity). Fix: 12-18 mo non-recoverable draw at 70-100% target; 18-24 mo for federal-clearance AEs.
Failure mode 8 — Geographic territory carving
Honeywell HQ NC + Cambridge UK + Phoenix AZ = one buyer, three AEs fighting for credit. Customer hears mixed messages + procurement gets confused + deal stalls. Fix: named-account model with vertical-aligned pods. One account = one global AE.
Adversarial counter — "should quantum AE comp be Big-Tech-style flat-base-no-variable?"
Some quantum CROs (reported at PsiQuantum + Atom Computing per industry interviews 2024) argue the whole comp question is wrong: quantum sales are really pre-sales engineering + algorithmic consulting, not selling, so AEs should be paid Big-Tech-style flat base $300-$400K + heavy RSU equity + zero variable, like Google/Apple/Meta principal-engineer comp.
Counter to the counter:
- Pre-sales is heavy in quantum but not 100% — there IS a deal-close discipline (CRADA negotiation + procurement orchestration + multi-stakeholder consensus) that benefits from commission incentive.
- Flat-base flight risk: high performers leave for variable-comp competitors that pay $700K+ for top deals.
- Flat-base culture risk: AE focus drifts toward technical exploration; deals stall at POC.
- Equity-only alignment: works at pre-IPO PsiQuantum + Atom Computing where IPO upside is mythic. Breaks at public IonQ/Rigetti/D-Wave where stock vol erases gains.
- The Zapata Computing collapse (Chapter 7 Aug 2024) is partly a story of cash-loaded equity-thin comp on pre-revenue de-SPAC stock — AEs couldn't survive when equity went to zero.
Where the flat-base argument holds: pre-revenue quantum cos (PsiQuantum + Atom Computing + Pasqal pre-IPO) reasonably load 70%+ of total comp in equity vs cash, with smaller cash variable. This is the "early-stage variant" of the hybrid model, not a refutation of it.
Honest 10-condition verdict — when each model works
| Condition | Use hybrid (recommended) | Use SaaS-style | Use flat-base equity |
|---|---|---|---|
| Public-co with disclosed AE comp pressure | ✓ | ||
| Pre-revenue with mythic IPO upside | ✓ | ||
| >40% government revenue mix | ✓ | ||
| >70% cloud/marketplace-routed | ✓ | ||
| 12-24 mo cycles | ✓ | ||
| 3-9 mo cycles (hyperscaler-routed) | ✓ | ||
| Strong IP/royalty pipeline | ✓ | ||
| Algorithm-consulting-led | ✓ | ||
| Heavy federal/lab/DARPA exposure | ✓ | ||
| Mature commercial product (Quantinuum, IonQ Forte) | ✓ | partial |
Default recommendation 2026-2027: hybrid (base $180-$250K + OTE $350-$500K + 60/40 + 1-2x quota + 50/30/20 vesting + IP kicker + 12-18 mo draw + no cap + named-account territory + USG-FY-aligned plan year for federal AEs). Adjust to early-stage equity-loaded variant if pre-revenue; adjust toward SaaS norms for hyperscaler-cloud pod.
Related Pulse RevOps entries
- AE Compensation Plan Design 101 — foundational SaaS AE comp structure (base/variable/quota/accelerator) that this quantum-specific entry contrasts with
- Sales Quota Setting Methods — quota multiplier theory (1-5x OTE) and how to anchor quota to historic win-rate × territory × ACV
- Sales Commission Plans for Long-Cycle Hard-Tech Sales — medical-device + semiconductor capital-equipment + aerospace long-cycle comp parallels
- Government-Contracting Sales Compensation — federal AE comp under FAR/DFARS + OTA + SBIR/STTR + USG fiscal-year alignment
- Equity Compensation for Pre-IPO Startups — RSU + ISO + NSO + pre-IPO option valuation + 4-yr/1-yr-cliff vesting
- Sales Territory Design — Named Account vs Geographic — when to switch from geo to named-account carving as deal complexity grows